Cabinet clears bonus for non-gazetted employees

30.67 lakh employees will benefit, total financial implication is Rs 3,737 crore

GN Bureau | October 21, 2020


#Union cabinet   #bureucracy   #bonus   #finance  
(Illustration: Ashish Asthana)
(Illustration: Ashish Asthana)

The union cabinet chaired by prime minister Narendra Modi on Wednesday gave its approval to pay productivity linked bonus (PLB) for 2019-20 to 16.97 lakh non-gazetted employees of commercial establishments like Railways, Posts, Defence, EPFO, and ESIC, with a financial implication of Rs.2,791 crore.

Non-PLB or ad-hoc bonus is given to non-gazetted central government employees. As many as 13.70 lakh employees will benefit and Rs.946 crore will be the financial implication for the same.

A total of 30.67 lakh employees will benefit from the Bonus announcement and total financial implication will be Rs 3,737 crore.

Payment of Bonus to non-gazetted employees for their performance in the preceding year is usually made before Durga Puja/Dussehra season. The government is announcing the PLB and ad hoc bonus for its non-gazetted employees to be disbursed immediately.
 

Comments

 

Other News

Celebrating the spirit woman with UN designated 14th Edition of the International Women’s Day Awards

Public Diplomacy Forum, in association with Tatsat Foundation, Business World and Governance Now is hosting "International Women`s Day Awards" for the true celebration of "STREE SHAKTI." This is a much-anticipated calendar event in New Delhi in its 14th edition which is a celebration of

BFSI Needs Military-grade Cybersecurity Solutions to Detect the Most Advanced Attacks: Deloitte

In such unprecedented times, businesses are facing different kinds of risk, which has

“New guidelines suppress digital, social media, and OTT platforms”

The government’s recent notification to regulate digital media is an attempt to suppress all social media platforms including digital news platforms, Dr. Shama Mohamed, Congress Spokesperson, has said. Only digital news platforms are able to say what they want to say, so the government

Covaxin Phase 3 clinical trial shows 81% efficacy

India’s first indigenously produced Covid-19 vaccine, Covaxin, has shown an interim efficacy of 81% in Phase III trials for preventing the virus. Covaxin has been developed in India jointly by the Indian Council of Medical Research (ICMR) along with Bharat Biotech International Limited (BBIL). &

In Mumbai, 29 private hospitals join vaccination drive

In order to expand the vaccination drive, the centre has allowed 29 private hospitals in Mumbai not empanelled in central and state health schemes to be designated as Covid Vaccination Centres (CVC). After a virtual meeting with the chief minister and the BMC commissioner Tuesday evening, th

Spectrum auction concludes; response better than expected

India on Tuesday concluded the spectrum auction after a total of six rounds of bidding. The authorities described the response as better than expected, with total bids valued at Rs 77,814.80 crore. The quality of service and customer experience is expected to improve with deployment of additional spectrum

Visionary Talk Series with Dr. Shama Mohamed On the present state of Governance



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter